US2005171135A1PendingUtilityA1
1'-[4-[1-(4-fluorophenyl)-1H-indole-3-Y1]-spiro[isobenzofuran-1(3H), 4'-piperidine]hydrohalogenides
Est. expiryNov 7, 2017(expired)· nominal 20-yr term from priority
A61P 9/10A61P 25/14A61P 25/16A61P 25/00A61P 25/28A61P 25/08A61P 25/18A61P 25/22A61P 21/00C07D 491/10C07D 491/107
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a hydrohalogenide of 1′-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4′-piperidine], pharmaceutical compositions containing the acid addition salts and the use thereof for the treatment of psychic and neurological disorders.
Claims
exact text as granted — not AI-modified1 - 4 . (canceled)
5 . A method for the treatment of a condition selected from the group consisting of anxiety, psychosis, epilepsy, convulsion, movement disorders, motor disturbances, amnesia, cerebrovascular diseases, senile dementia of Alzheimer type and Parkinson's disease, comprising administering a therapeutically effective amount of a hydrohalogenide of 1′-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H), 4′-piperidine] or hydrate or solvate thereof to a subject suffering from such a condition.
6 . The method according to claim 5 wherein anxiety is treated.
7 . The method according to claim 5 wherein the hydrohalogenide is the hydrochloride.Join the waitlist — get patent alerts
Track US2005171135A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.